News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Singulex, Inc. Secures $55 Million in Debt and Equity Financing


9/26/2013 9:47:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ALAMEDA, Calif.--(BUSINESS WIRE)--Singulex, Inc., the leading provider of Single Molecule Counting (SMC™) technology for scientific discovery and clinical testing services, today announced it has secured a debt facility for up to $40 million from Oxford Finance and Silicon Valley Bank. In June 2013, the Company also raised $15 million in equity financing. The Company will use the funding to advance the development and commercialization of a global in vitro diagnostics business based on Singulex’s SMC technology.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES